{"id":"W2564318420","doi":"10.1186/s40425-016-0173-6","title":"31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two","year":2016,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Columbia College; Caprion (Canada)","funders":"National Institute of Neurological Disorders and Stroke; Stand Up To Cancer; National Institutes of Health; Knight Cancer Institute, Oregon Health and Science University; Cancer Research Society; European Commission; U.S. Department of Defense; Breast Cancer Research Foundation; Oregon Health and Science University; Prostate Cancer Foundation; Movember Foundation; Cancer League of Colorado; Harry J. Lloyd Charitable Trust; National Cancer Institute; Dendreon Pharmaceuticals; Melanoma Research Alliance; Susan G. Komen for the Cure; Pharmaceutical Research and Manufacturers of America Foundation; Amgen; Collins Medical Trust","keywords":"Prostate cancer; Immunotherapy; Cancer immunotherapy; Myeloid cells; Cancer; Medicine; Gerontology; Immunology; Oncology; Cancer research; Myeloid; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001949545,0.001153058,0.0007887704,0.001471728,0.0007779325,0.00224529,0.001121444,0.002323588,0.1736784],"category_scores_gemma":[0.002683547,0.000325983,0.000748485,0.0008041231,0.0003601488,0.001005457,0.001474979,0.002265147,0.1298659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001032392,"about_ca_system_score_gemma":0.003033836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001072354,"about_ca_topic_score_gemma":0.00252197,"domain_scores_codex":[0.999211,0.000126168,0.0000664466,0.00008476359,0.0003778747,0.0001337786],"domain_scores_gemma":[0.9968789,0.0001998712,0.0002239292,0.0001267419,0.001350524,0.00122013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000226486,0.0001919806,0.0004696271,0.0003335772,0.00001241102,0.0000949582,0.00001532359,0.0001493785,0.00238342,0.0005375224,0.8581689,0.1374164],"study_design_scores_gemma":[0.00003802259,0.0001081193,0.001441502,0.0001411045,0.000008076999,0.0001617575,0.00001635696,0.000211786,0.0006028499,0.0004449901,0.9968178,0.000007517105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01059754,0.04701954,0.008501466,0.09180977,0.2764674,0.003652807,0.01055225,0.001964801,0.5494344],"genre_scores_gemma":[0.01238766,0.03547033,0.00447973,0.0087888,0.07224985,0.001356528,0.01127149,0.0005351713,0.8534604],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.1736784,"threshold_uncertainty_score":0.5810121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01995262355944799,"score_gpt":0.3311051548978156,"score_spread":0.3111525313383676,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}